345 related articles for article (PubMed ID: 12421096)
1. DNA testing for familial hypercholesterolemia: improving disease recognition and patient care.
Vergopoulos A; Knoblauch H; Schuster H
Am J Pharmacogenomics; 2002; 2(4):253-62. PubMed ID: 12421096
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia.
Miltiadous G; Xenophontos S; Bairaktari E; Ganotakis M; Cariolou M; Elisaf M
Pharmacogenet Genomics; 2005 Apr; 15(4):219-25. PubMed ID: 15864114
[TBL] [Abstract][Full Text] [Related]
4. An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia.
Dušková L; Kopečková L; Jansová E; Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
Atherosclerosis; 2011 May; 216(1):139-45. PubMed ID: 21310417
[TBL] [Abstract][Full Text] [Related]
5. The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia.
Heath KE; Gudnason V; Humphries SE; Seed M
Atherosclerosis; 1999 Mar; 143(1):41-54. PubMed ID: 10208479
[TBL] [Abstract][Full Text] [Related]
6. Cascade screening for familial hypercholesterolemia: Practical consequences.
Louter L; Defesche J; Roeters van Lennep J
Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
[TBL] [Abstract][Full Text] [Related]
8. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel LDLR disease-causing variant using capture-based next-generation sequencing screening of familial hypercholesterolemia patients in Taiwan.
Hsiung YC; Lin PC; Chen CS; Tung YC; Yang WS; Chen PL; Su TC
Atherosclerosis; 2018 Oct; 277():440-447. PubMed ID: 30270083
[TBL] [Abstract][Full Text] [Related]
10. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction.
Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H
Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288
[TBL] [Abstract][Full Text] [Related]
11. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
[TBL] [Abstract][Full Text] [Related]
12. Low density lipoprotein--receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia.
Punzalan FE; Sy RG; Santos RS; Cutiongco EM; Gosiengfiao S; Fadriguilan E; George P; Laurie A
J Atheroscler Thromb; 2005; 12(5):276-83. PubMed ID: 16205024
[TBL] [Abstract][Full Text] [Related]
13. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
[TBL] [Abstract][Full Text] [Related]
14. My Approach to the Patient With Familial Hypercholesterolemia.
Safarova MS; Kullo IJ
Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
[TBL] [Abstract][Full Text] [Related]
15. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
[TBL] [Abstract][Full Text] [Related]
16. Whole-exome sequencing in an extended family with myocardial infarction unmasks familial hypercholesterolemia.
Brænne I; Reiz B; Medack A; Kleinecke M; Fischer M; Tuna S; Hengstenberg C; Deloukas P; Erdmann J; Schunkert H;
BMC Cardiovasc Disord; 2014 Aug; 14():108. PubMed ID: 25154303
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction.
Cui Y; Li S; Zhang F; Song J; Lee C; Wu M; Chen H
Clin Cardiol; 2019 Mar; 42(3):385-390. PubMed ID: 30637778
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
[TBL] [Abstract][Full Text] [Related]
19. Familial hypercholesterolemia--improving treatment and meeting guidelines.
Hopkins PN
Int J Cardiol; 2003 May; 89(1):13-23. PubMed ID: 12727001
[TBL] [Abstract][Full Text] [Related]
20. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
